HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fabio Ferrari Selected Research

Critical Illness (Critically Ill)

10/2009Nebulized ceftazidime in experimental pneumonia caused by partially resistant Pseudomonas aeruginosa.
1/2008Echocardiographic Doppler estimation of pulmonary artery pressure in critically ill patients with severe hypoxemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fabio Ferrari Research Topics

Disease

4Chronic Obstructive Pulmonary Disease (COPD)
01/2014 - 10/2011
2Spontaneous Coronary Artery Dissection
12/2021 - 01/2021
2Myocardial Infarction
01/2021 - 06/2019
2Hemorrhage
12/2020 - 06/2019
2Critical Illness (Critically Ill)
10/2009 - 01/2008
2Pneumonia (Pneumonitis)
10/2009 - 11/2002
2Bronchopneumonia
05/2005 - 11/2002
1Pain (Aches)
07/2021
1Chronic Pain
07/2021
1Postoperative Pain
07/2021
1Neoplasms (Cancer)
01/2020
1Thrombosis (Thrombus)
06/2019
1Stroke (Strokes)
06/2019
1Acute Coronary Syndrome
06/2019
1Systemic Scleroderma (Systemic Sclerosis)
08/2018
1Localized Scleroderma (Morphea)
08/2018
1Polymyositis
01/2016
1Myositis (Idiopathic Inflammatory Myopathies)
01/2016
1Dermatomyositis (Dermatopolymyositis)
01/2016
1Myopia
01/2015
1Retinal Detachment (Retinal Detachments)
01/2015
1Ventilator-Associated Pneumonia
10/2009
1Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
01/2008
1Hypoxia (Hypoxemia)
01/2008
1Acute Lung Injury
01/2008
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2007
1Inflammation (Inflammations)
01/2007
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2007
1Myocardial Ischemia (Ischemic Heart Diseases)
04/2005

Drug/Important Bio-Agent (IBA)

2omega-Chloroacetophenone (Mace)IBA
01/2021 - 06/2019
2AutoantibodiesIBA
08/2018 - 01/2016
2AntibodiesIBA
08/2018 - 01/2016
2Biomarkers (Surrogate Marker)IBA
01/2014 - 10/2011
2ElastinIBA
01/2014 - 10/2011
2DesmosineIBA
11/2012 - 10/2011
2Ceftazidime (Fortum)FDA LinkGeneric
10/2009 - 05/2005
2Oxygen (Dioxygen)IBA
01/2008 - 05/2005
1Analgesics (Analgesic Drugs)IBA
07/2021
1Anesthetics (Anesthetic Agents)IBA
07/2021
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
12/2020
1LectinsIBA
01/2020
1bivalirudin (Angiomax)FDA Link
06/2019
1Heparin (Liquaemin)FDA LinkGeneric
06/2019
1AntigensIBA
08/2018
1Antinuclear AntibodiesIBA
08/2018
1Rheumatoid FactorIBA
08/2018
1Histones (Histone)IBA
08/2018
1Ligases (Synthetase)IBA
01/2016
1Cell ExtractsIBA
01/2016
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2015
1Fluorescein (Funduscein)FDA LinkGeneric
01/2015
1Proteins (Proteins, Gene)FDA Link
10/2012
1ProteomeIBA
10/2012
1IsodesmosineIBA
10/2011
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2007
1C-Reactive ProteinIBA
01/2007
1NitrogenIBA
05/2005
1AerosolsIBA
05/2005
1HeliumIBA
05/2005
1Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric
04/2005
1Amikacin (A.M.K)FDA LinkGeneric
11/2002

Therapy/Procedure

3Therapeutics
12/2021 - 01/2021
3Intravenous Administration
10/2009 - 11/2002
2Stents
12/2020 - 06/2019
1Anesthesia
07/2021
1Thoracotomy
07/2021
1Percutaneous Coronary Intervention
01/2021
1Conservative Treatment
01/2021
1Lasers (Laser)
11/2012
1Artificial Respiration (Mechanical Ventilation)
01/2008
1Catheters
01/2008
1Positive-Pressure Respiration (Positive End-Expiratory Pressure)
01/2007